Effect on Off-Label Marketing in the 2010 Budget Details?
The Department of Health and Human Services recently released its budget proposal for 2010. As it relates to the FDA, HHS is looking to build…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormTag Archives: U.S. Food and Drug Administration
Eli Lilly has Fighting Words for W. Virginia Attorney General
Attorneys representing Eli Lilly & Co. claim that the civil penalties sought by West Virginia Attorney General Darrell McGraw for the pharmaceutical manufacturer's alleged mislabeling…
Read More »Senator Requests Clarification of Recent Memo to FDA Employees
U.S. Sen. Chuck Grassley wrote a letter on March 24, 2009 to FDA's acting commissioner asking for clarification of a recent memo to FDA employees,…
Read More »FDA approves Ranbaxy Laboratories’ drugs despite allegations of fraud and more
FDA has approved 18 products, including generic versions of commonly used cholesterol and allergy medications, by pharmaceutical giant Ranbaxy Laboratories, even though the government has…
Read More »Eli Lilly Pays Record Fine for Off-Label Drug Marketing
Philadelphia, Pennsylvania— Multiple news publications have confirmed that Eli Lilly & Co. will, in the largest United States-imposed criminal fine on an individual company, pay…
Read More »CRO’s Conflict of Interest
St. Petersburg Reporter Chris Hundley wrote (July 1, 2007) a well-written, balanced and comprehensive (as can get in an article) about Contract Research Organizations (CRO’s). …
Read More »Clinical investigator indicted for fraud in pharmaceutical trials of blockbuster drug
NEW ORLEANS — Dr. Maria Carmen Palazzo was indicted by a federal grand jury on 55 counts of health care fraud and false documentation in…
Read More »Purdue Pharma Agrees to $19.5 Million Settlement Over Off Label Marketing of OxyContin
Purdue Pharma has agreed to settle claims by 26 states and the District of Columbia for marketing and promoting OxyContin for unapproved uses i.e. for…
Read More »FDA Launches Draft Guidelines On Financial Ties With Drug Companies
If an outside expert has more than $50,000 in ties to drug and medical device companies regulated by the Food and Drug Administration he will…
Read More »Aventis Aware of Fraudulent Data Regarding Ketek Says CRO Employee
A former staff member of the Pharmaceutical Product Development (PPD) has claimed that Aventis and PPD - the contract research organization (CRO) hired by Aventis-…
Read More »